OwnershipPublicly listed · Nasdaq: VANISEC EDGAR company record and tickers file (Nasdaq: VANI) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: VANI, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
5developments published
—US federal obligations on record
1private-offering notices since 2019
Aug 13, 2026latest development
Timeline
- Aug 13, 2026 · Reported results
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
Company-reported - Aug 6, 2026 · Company announcement
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Company-reported - Jul 1, 2026 · Material agreement
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight
Company-reported - Jun 24, 2026 · Leadership change
Vivani Medical reports changes involving its directors or officers (Form 8-K, Item 5.02)
Regulatory filing - May 13, 2026 · Reported results
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Company-reported
Profile
- Legal name
- Vivani Medical, Inc.
- Listing
- Nasdaq VANI
- SEC filer
- CIK 0001266806 ↗
- SEC industry code
- Electromedical & Electrotherapeutic Apparatus
- Incorporated
- DE
- Coverage
- Filings + federal awards
Watch Vivani Medical
Anything new from Vivani Medical lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Apr 7, 2021 | D | $27.9 million | $27.9 million | Mar 26, 2021 | 7 | Rule 506(b) | SEC ↗ |